Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Lessened by Shell Asset Management Co.
Shell Asset Management Co. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,629 shares of the biopharmaceutical company’s stock after selling 1,250 shares during the […]